Literature DB >> 22876158

Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma.

A Abu-Sanad1, A Warsi, R P Michel, A Nahal, G Popradi, J M Storring, A S Liberman, T Alcindor.   

Abstract

Histiocytic sarcoma is diagnosed according to established criteria. However, treatment is controversial: although lymphoma chemotherapy regimens are often used, their impact on the natural history of the disease is unclear. Here, we report a disease-free survival of 2 years after autologous stem-cell transplantation in a patient with relapsed histiocytic sarcoma.

Entities:  

Keywords:  Histiocytic sarcoma; chemotherapy; stem-cell transplantation

Year:  2012        PMID： 22876158      PMCID： PMC3410841          DOI： 10.3747/co.19.964

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


  9 in total

1.  [Allogeneic bone marrow transplantation for a patient with malignant histiocytosis].

Authors:  M Zhai; L Hu; H Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  1997-08

Review 2.  A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant.

Authors:  Chiara Mainardi; Emanuele S G D'Amore; Marta Pillon; Tiziana Toffolutti; Angelo Rosolen
Journal:  Leuk Lymphoma       Date:  2011-03-22

Review 3.  Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature.

Authors:  Usama Gergis; Hendrik Dax; Ellen Ritchie; Rachel Marcus; Usama Wissa; Attilio Orazi
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

4.  Successful autologous bone marrow transplantation in second remission of malignant histiocytosis.

Authors:  B Cazin; N C Gorin; J P Jouet; J P Laporte; P Fenaux; M P Walter; A Najman; B Gosselin; F Bauters
Journal:  Bone Marrow Transplant       Date:  1990-06       Impact factor: 5.483

5.  Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163.

Authors:  Jeffrey A Vos; Susan L Abbondanzo; Carol L Barekman; Joann W Andriko; Markku Miettinen; Nadine S Aguilera
Journal:  Mod Pathol       Date:  2005-05       Impact factor: 7.842

6.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

7.  Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.

Authors:  Jason L Hornick; Elaine S Jaffe; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

8.  A case of primary histiocytic sarcoma arising from thyroid gland.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Pathol Oncol Res       Date:  2009-08-05       Impact factor: 3.201

9.  Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

Authors:  Muneer H Abidi; Isaacson Tove; Rami B Ibrahim; Dan Maria; Edward Peres
Journal:  Am J Hematol       Date:  2007-10       Impact factor: 10.047
  9 in total
  3 in total

1.  Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation.

Authors:  Hideki Tsujimura; Toshiko Miyaki; Shuhei Yamada; Takeaki Sugawara; Mikiko Ise; Shintaro Iwata; Tsukasa Yonemoto; Dai Ikebe; Makiko Itami; Kyoya Kumagai
Journal:  Int J Hematol       Date:  2014-07-26       Impact factor: 2.490

2.  Histiocytic sarcoma combined with acute monocytic leukemia: a case report.

Authors:  Jiangning Zhao; Xiaoqing Niu; Zhao Wang; Huadong Lu; Xiaoyan Lin; Quanyi Lu
Journal:  Diagn Pathol       Date:  2015-07-19       Impact factor: 2.644

3.  Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery.

Authors:  Masafumi Oto; Akiko Maeda; Taku Nose; Yujiro Ueda; Shima Uneda; Akito Inadome; Koichi Oshima; Minoru Yoshida
Journal:  Intern Med       Date:  2017-09-15       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.